Transcriptional Characterization of Glioma Neural Stem Cells Diva ...

More documents

Recommendations

Info

[94] F. Chibon, O. Mariani, J. Derré, A. Mairal, J. Coindre, L. Guillou, X. Sastre, F. Pédeutour, and A. Aurias. Ask1 (map3k5) as a potential therapeutic target in malignant fibrous histiocytomas with 12q14–q15 and 6q23 amplifications. Genes, Chromosomes and Cancer, 40(1):32–37, 2004. [95] S. Chigurupati, R. Venkataraman, D. Barrera, A. Naganathan, M. Madan, L. Paul, J. Pattisapu, G. Kyriazis, K. Sugaya, S. Bushnev, et al. Receptor channel trpc6 is a key mediator of notch-driven glioblastoma growth and invasiveness. Cancer research, 70(1):418–427, 2010. [96] E. Chiocca. The many functions of microRNAs in glioblastoma. World neurosurgery, 2010. [97] S. Chirasani, A. Sternjak, P. Wend, S. Momma, B. Campos, I. Herrmann, D. Graf, T. Mitsiadis, C. Herold-Mende, D. Besser, et al. Bone morphogenetic protein-7 release from endogenous neural precursor cells suppresses the tumourigenicity of stem-like glioblastoma cells. Brain, 133(7):1961–1972, 2010. [98] M. Choi, U. Scholl, W. Ji, T. Liu, I. Tikhonova, P. Zumbo, A. Nayir, A. Bakkaloğlu, S. Özen, S. Sanjad, et al. Genetic diagnosis by whole exome capture and massively parallel dna sequencing. Proceedings of the National Academy of Sciences, 106(45):19096– 19101, 2009. [99] L. M. Chow and S. J. Baker. PTEN function in normal and neoplastic growth. Cancer letters, 241(2):184–196, Sept. 2006. [100] L. M. Chow, R. Endersby, X. Zhu, S. Rankin, C. Qu, J. Zhang, A. Broniscer, D. W. Ellison, and S. J. Baker. Cooperativity within and among Pten, p53, and Rb pathways induces high-grade astrocytoma in adult brain. Cancer Cell, 19(3):305–16, 2011. [101] M. J. Clark, N. Homer, B. D. O’Connor, Z. Chen, A. Eskin, H. Lee, B. Merriman, and S. F. Nelson. U87MG decoded: the genomic sequence of a cytogenetically aberrant human cancer cell line. PLoS genetics, 6(1):e1000832, 2010. [102] N. M. Cohen, E. Kenigsberg, and A. Tanay. Primate CpG islands are maintained by heterogeneous evolutionary regimes involving minimal selection. Cell, 145(5):773–786, May 2011. [103] A. Collins, P. Berry, C. Hyde, M. Stower, and N. Maitland. Prospective identification of tumorigenic prostate cancer stem cells. Cancer research, 65(23):10946, 2005. [104] V. Collins. Amplified genes in human gliomas. In Seminars in cancer biology, volume 4, page 27, 1993. [105] H. Colman, L. Zhang, E. Sulman, J. McDonald, N. Shooshtari, A. Rivera, S. Popoff, C. Nutt, D. Louis, J. Cairncross, et al. A multigene predictor of outcome in glioblastoma. Neuro-oncology, 12(1):49–57, 2010. [106] G. O. Consortium et al. Gene ontology: tool for the unification of biology. Nature genetics, 25(1):25–29, 2000. [107] L. Conti, S. M. Pollard, T. Gorba, E. Reitano, M. Toselli, G. Biella, Y. Sun, S. Sanzone, Q.-L. Ying, E. Cattaneo, and A. Smith. Niche-Independent Symmetrical Self-Renewal of a Mammalian Tissue Stem Cell. PLoS Biology, 3(9):e283, 2005. [108] H. Contreras, R. Ledezma, J. Vergara, F. Cifuentes, C. Barra, P. Cabello, I. Gallegos, B. Morales, C. Huidobro, and E. Castellón. The expression of syndecan-1 and-2 is associated with gleason score and epithelial-mesenchymal transition markers, ecadherin and β-catenin, in prostate cancer. In Urologic Oncology: Seminars and Original Investigations, volume 28, pages 534–540. Elsevier, 2010. [109] A. Coutts, E. MacKenzie, E. Griffith, and D. Black. Tes is a novel focal adhesion protein with a role in cell spreading. Journal of cell science, 116(5):897–906, 2003. [110] Y. Cui, J. Wang, X. Zhang, R. Lang, M. Bi, L. Guo, and S. Lu. Ecrg2, a novel candidate of tumor suppressor gene in the esophageal carcinoma, interacts directly with metallothionein 2a and links to apoptosis* 1,* 2,* 3. Biochemical and biophysical research communications, 302(4):904–915, 2003. [111] M. Cully, H. You, and A. Levine. Beyond PTEN mutations: the PI3K pathway as an integrator of multiple inputs during tumorigenesis. Nature Reviews Cancer, 2006.
[112] M. Czystowska, J. Han, M. Szczepanski, M. Szajnik, K. Quadrini, H. Brandwein, J. Hadden, K. Signorelli, and T. Whiteside. Irx-2, a novel immunotherapeutic, protects human t cells from tumor-induced cell death. Cell Death & Differentiation, 16(5):708– 718, 2009. [113] C. Dang, M. Gottschling, K. Manning, E. O’Currain, S. Schneider, W. Sterry, E. Stockfleth, and I. Nindl. Identification of dysregulated genes in cutaneous squamous cell carcinoma. Oncology reports, 16(3):513–519, 2006. [114] L. De Filippis, G. Lamorte, E. Snyder, A. Malgaroli, and A. Vescovi. A novel, immortal, and multipotent human neural stem cell line generating functional neurons and oligodendrocytes. Stem cells, 25(9):2312–2321, 2007. [115] C. Dehay and H. Kennedy. Cell-cycle control and cortical development. Nature Reviews Neuroscience, 8(6):438–450, 2007. [116] L. Deleyrolle and B. Reynolds. Isolation, expansion, and differentiation of adult mammalian neural stem and progenitor cells using the neurosphere assay. Methods Mol Biol, 549:91–101, 2009. [117] G. Denning, B. Jean-Joseph, C. Prince, D. Durden, and P. Vogt. A short n-terminal sequence of pten controls cytoplasmic localization and is required for suppression of cell growth. Oncogene, 26(27):3930–3940, 2007. [118] C. Desmet and D. Peeper. The neurotrophic receptor trkb: a drug target in anti-cancer therapy? Cellular and molecular life sciences, 63(7):755–759, 2006. [119] L. Desnoyers, R. Pai, R. Ferrando, K. Hötzel, T. Le, J. Ross, R. Carano, A. D’Souza, J. Qing, I. Mohtashemi, et al. Targeting fgf19 inhibits tumor growth in colon cancer xenograft and fgf19 transgenic hepatocellular carcinoma models. Oncogene, 27(1):85– 97, 2007. [120] T. Di Tomaso, S. Mazzoleni, E. Wang, G. Sovena, D. Clavenna, A. Franzin, P. Mortini, S. Ferrone, C. Doglioni, F. Marincola, et al. Immunobiological characterization of cancer stem cells isolated from glioblastoma patients. Clinical Cancer Research, 16(3):800–813, 2010. [121] P. Dirks. Stem cells and brain tumours. Nature, 444(7120):687–688, 2006. [122] P. Dirks. Brain tumour stem cells: the undercurrents of human brain cancer and their relationship to neural stem cells. Philosophical Transactions of the Royal Society B: Biological Sciences, 363(1489):139, 2008. [123] P. B. Dirks. Cancer: stem cells and brain tumours. Nature, 444(7120):687–8, 2006. [124] J. G. Doench and P. A. Sharp. Specificity of microRNA target selection in translational repression. Genes Dev, 18(5):504–11, 2004. [125] T. Doetschman, H. Eistetter, M. Katz, W. Schmidt, and R. Kemler. The in vitro development of blastocyst-derived embryonic stem cell lines: formation of visceral yolk sac, blood islands and myocardium. Journal of embryology and experimental morphology, 87(1):27, 1985. [126] S. Dolci, A. Belmonte, R. Santone, M. Giorgi, M. Pellegrini, E. Carosa, E. Piccione, A. Lenzi, and E. Jannini. Subcellular localization and regulation of type-1c and type-5 phosphodiesterases. Biochemical and biophysical research communications, 341(3):837–846, 2006. [127] G. Dominic, W. Yi-Lu, L. David, and R. Nikolaus. microrna target predictions across seven drosophila species and comparison to mammalian targets. 2005. [128] D. Doyle, G. Hanks, and N. Cherny. Oxford textbook of palliative medicine. Oxford University Press, USA, 2005. [129] T. Du. microPrimer: the biogenesis and function of microRNA. Development, 132(21):4645–4652, Sept. 2005. [130] A. Duensing and S. Duensing. Guilt by association? p53 and the development of aneuploidy in cancer. Biochemical and biophysical research communications, 331(3):694– 700, 2005. [131] H. Dvinge and P. Bertone. Htqpcr: high-throughput analysis and visualization of quantitative real-time pcr data in r. Bioinformatics, 25(24):3325–3326, 2009.
Page 1 and 2:
Transcriptional Characterization of
Page 3 and 4:
This dissertation is my own work an
Page 5 and 6:
Acknowledgements I would like to th
Page 7 and 8:
5.9 External Dataset Expression Cor
Page 9 and 10:
Introduction 1
Page 11 and 12:
1.1 Glial Cells in the Central Nerv
Page 13 and 14:
1.2 Glioblastoma Multiforme Introdu
Page 15 and 16:
Page 17 and 18:
Page 19 and 20:
1.3 Primary and Secondary Glioblast
Page 21 and 22:
Page 23 and 24:
Page 25 and 26:
Page 27 and 28:
Page 29 and 30:
1.4 Pathways Involved in Glioblasto
Page 31 and 32:
Page 33 and 34:
Page 35 and 36:
Page 37 and 38:
Page 39 and 40:
1.5 Pathway Crosstalk Introduction
Page 41 and 42:
Chapter 2 Neurogenesis Contents 2.1
Page 43 and 44:
2.1 Radial Glia Introduction VZ adj
Page 45 and 46:
2.2 Neural Stem Cells Introduction
Page 47 and 48:
Page 49 and 50:
Page 51 and 52:
Page 53 and 54:
Page 55 and 56:
Page 57 and 58:
Page 59 and 60:
Page 61 and 62:
Page 63 and 64:
Page 65 and 66:
Chapter 3 Brain Cancer Stem Cells C
Page 67 and 68:
3.1 The Cancer Stem Cell Hypothesis
Page 69 and 70:
3.1 The Cancer Stem Cell Hypothesis
Page 71 and 72:
3.2 Brain Cancer Stem Cells Introdu
Page 73 and 74:
Page 75 and 76:
Page 77 and 78:
Page 79 and 80:
Page 81 and 82:
3.3 Glioma Culture Systems Introduc
Page 83 and 84:
Page 85 and 86:
Page 87 and 88:
Page 89 and 90:
Page 91 and 92:
Page 93 and 94:
Chapter 4 The Non-Coding RNA World
Page 95 and 96:
4.1 MicroRNA regulation Introductio
Page 97 and 98:
4.1 MicroRNA regulation Introductio
Page 99 and 100:
4.2 Target Prediction and Validatio
Page 101 and 102:
Methods 93
Page 103 and 104:
5.1 Tag-sequencing Data Processing
Page 105 and 106:
5.1 Tag-sequencing Data Processing
Page 107 and 108:
5.2 Array Comparative Genomic Hybri
Page 109 and 110:
5.4 Quantitative Real Time-PCR Vali
Page 111 and 112:
Page 113 and 114:
Page 115 and 116:
5.5 Literature Mining Methods Figur
Page 117 and 118:
5.5 Literature Mining Methods How m
Page 119 and 120:
5.6 Differential Isoform Expression
Page 121 and 122:
5.9 External Dataset Expression Cor
Page 123 and 124:
5.10 Glioblastoma Pathway Construct
Page 125 and 126:
5.11 MicroRNA Target Prediction Ana
Page 127 and 128:
Results 119
Page 129 and 130:
6.2 Tag mapping Results Table 6.1:
Page 131 and 132:
6.2 Tag mapping Results 123 Figure
Page 133 and 134:
6.3 Copy Number Aberrations Results
Page 135 and 136:
6.3 Copy Number Aberrations Results
Page 137 and 138:
6.4 Core Differentially Expressed G
Page 139 and 140:
Page 141 and 142:
Page 143 and 144:
Page 145 and 146:
6.5 Large-scale qRT-PCR Validation
Page 147 and 148:
Page 149 and 150:
Page 151 and 152:
6.6 Literature Mining for Different
Page 153 and 154:
6.7 Isoform Differential Expression
Page 155 and 156:
Page 157 and 158:
Page 159 and 160:
Page 161 and 162:
Page 163 and 164:
Page 165 and 166:
6.8 Long ncRNA Differential Express
Page 167 and 168:
6.8 Long ncRNA Differential Express
Page 169 and 170:
Chapter 7 Dataset Correlation Analy
Page 171 and 172:
7.1 Enrichment Analysis Results Tab
Page 173 and 174:
7.1 Enrichment Analysis Results Fig
Page 175 and 176:
7.1 Enrichment Analysis Results Tab
Page 177 and 178:
7.2 Glioblastoma Expression Signatu
Page 179 and 180:
7.3 Tumour Expression Correlation R
Page 181 and 182:
Page 183 and 184:
Page 185 and 186:
Page 187 and 188:
Page 189 and 190:
Page 191 and 192:
7.4 Survival Analysis Results Table
Page 193 and 194:
7.4 Survival Analysis Results 867 g
Page 195 and 196:
7.5 Glioblastoma Pathway Analysis R
Page 197 and 198:
Page 199 and 200:
Page 201 and 202:
Page 203 and 204:
Page 205 and 206:
Page 207 and 208:
Page 209 and 210:
Page 211 and 212:
8.1 Principles Results say, this is
Page 213 and 214:
8.3 Databases Results Figure 8.1: O
Page 215 and 216:
8.3 Databases Results Figure 8.3: W
Page 217 and 218:
8.4 Filters Results Bayesian method
Page 219 and 220:
8.5 Target Prediction Ensemble Anal
Page 221 and 222:
Page 223 and 224:
Page 225 and 226:
Page 227 and 228:
Page 229 and 230:
9.1. Digital Profiling of GNS Cell
Page 231 and 232:
Page 233 and 234:
Page 235 and 236:
Page 237 and 238:
Page 239 and 240:
9.2. MicroRNA Target Prediction Ana
Page 241 and 242:
9.3. Concluding Remarks Appendix pr
Page 243 and 244:
A.1 Differential Expression Appendi
Page 245 and 246:
Page 247 and 248:
Page 249 and 250:
Page 251 and 252:
Page 253 and 254:
Page 255 and 256:
Page 257 and 258:
Page 259 and 260:
A.2 Classified Differential Express
Page 261 and 262:
Page 263 and 264:
Page 265 and 266:
A.3 Quantitative RT-PCR Appendix Ta
Page 267 and 268:
A.3 Quantitative RT-PCR Appendix We
Page 269 and 270:
A.3 Quantitative RT-PCR Appendix Ta
Page 271 and 272:
A.3 Quantitative RT-PCR Appendix We
Page 273 and 274:
A.4 Tag-seq vs qRT-PCR Correlation
Page 275 and 276:
Appendix "BEX5", "DIAPH2", "GBP3",
Page 277 and 278: End Select End If End Sub Appendix
Page 279 and 280: If NameStr.ToLower().Equals("query"
Page 281 and 282: Appendix C Long ncRNAs We detected
Page 283 and 284: C. Long ncRNAs Appendix Tag Accessi
Page 285 and 286: D.1 Pathway Interactions Appendix F
Page 291 and 292: D.2 Pathway Images Appendix Figure
Page 293 and 294: D.2 Pathway Images Appendix Figure
Page 295 and 296: E. Exon Array Data Appendix Average
Page 309 and 310: F. MicroRNA Array Data Appendix Tab
Page 311 and 312: F. MicroRNA Array Data Appendix GNS
Page 313 and 314: F. MicroRNA Array Data Appendix GNS
Page 315 and 316: Ln Natural logarithm LOH Loss of He
Page 317 and 318: 3.3 Schematisation of cell cycle ph
Page 319 and 320: 8.3 Workflows at the core of the pr
Page 321 and 322: 7.1 Selected Gene Ontology terms an
Page 323 and 324: Bibliography [1] Cell signaling tec
Page 325 and 326: [38] G. Bain, D. Kitchens, M. Yao,
Page 327: [78] S. Bustin, V. Benes, J. Garson
Page 331 and 332: [153] T. Fujiwara, M. Bandi, M. Nit
Page 333 and 334: [192] M. Hernandez, M. Nieto, and M
Page 335 and 336: [231] T.-M. Kim, W. Huang, R. Park,
Page 337 and 338: [268] H. Lemjabbar-Alaoui, A. van Z
Page 339 and 340: [305] K. MAEDA, S. MATSUHASHI, K. T
Page 341 and 342: [342] H. Moon, M. Ahn, J. Park, K.
Page 343 and 344: [379] D. Park and J. Rich. Biology
Page 345 and 346: [417] P. Rakic. Guidance of neurons
Page 347 and 348: [456] T. Shima, N. Okumura, T. Taka
Page 349 and 350: [490] P. A. C. t’Hoen, Y. Ariyure
Page 351 and 352: [523] T. Watanabe, A. Takeda, T. Ts
show all

Transcriptional Characterization of Glioma Neural Stem Cells Diva ...

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?